G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $261,000 | -25.4% | 34,400 | +0.3% | 0.00% | – |
| Q4 2021 | $350,000 | -23.9% | 34,300 | 0.0% | 0.00% | – |
| Q3 2021 | $460,000 | -38.9% | 34,300 | 0.0% | 0.00% | – |
| Q2 2021 | $753,000 | -19.7% | 34,300 | -12.1% | 0.00% | – |
| Q1 2021 | $938,000 | +119.2% | 39,000 | +63.9% | 0.00% | – |
| Q4 2020 | $428,000 | -15.9% | 23,800 | -46.0% | 0.00% | – |
| Q3 2020 | $509,000 | -53.3% | 44,100 | -1.8% | 0.00% | -100.0% |
| Q2 2020 | $1,089,000 | +120.0% | 44,900 | 0.0% | 0.00% | – |
| Q1 2020 | $495,000 | -58.3% | 44,900 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $1,187,000 | +9.7% | 44,900 | -5.5% | 0.00% | 0.0% |
| Q3 2019 | $1,082,000 | -25.7% | 47,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,456,000 | +229.4% | 47,500 | +78.6% | 0.00% | – |
| Q1 2019 | $442,000 | -20.9% | 26,600 | -8.9% | 0.00% | – |
| Q4 2018 | $559,000 | -64.2% | 29,200 | -2.3% | 0.00% | -100.0% |
| Q3 2018 | $1,563,000 | +20.3% | 29,900 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,299,000 | – | 29,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |